Viewing Study NCT05006183



Ignite Creation Date: 2024-05-06 @ 4:29 PM
Last Modification Date: 2024-10-26 @ 2:11 PM
Study NCT ID: NCT05006183
Status: UNKNOWN
Last Update Posted: 2022-04-29
First Post: 2021-08-02

Brief Title: Instantaneous Wave-free Ratio Guidance Strategy Evaluation in the Treatment of Multivessel Acute Coronary Syndrome
Sponsor: Daugavpils Regional Hospital
Organization: Daugavpils Regional Hospital

Study Overview

Official Title: Characterization of Coronary Artery Hemodynamic Measurements and Virtual Angioplasty Planning by Instantaneous Wave-free Ratio iFR in Multivessel Acute Coronary Syndrome Patients With Evaluation of the Impact on Clinical Outcomes
Status: UNKNOWN
Status Verified Date: 2022-04
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: iStrategy
Brief Summary: A single-center prospective randomized open-label blinded end-point clinical trial of instantaneous wave-free ratio iFR guidance strategy impact on clinical outcomes in multivessel acute coronary syndrome ACS patients
Detailed Description: The all-comers study population consists of hemodynamically stable de novo ACS patients with a stenosis of 50 and more by visual estimation in at least two separate coronary arteries with Thrombolysis in Myocardial Infarction TIMI flow 2 and willing to sign a patient informed consent ACS diagnosis established by angina pectoris symptoms andor ECG changes andor hs-troponin I levels The use of drug-eluting stents is mandatory in both treatment groups In the intervention strategy group patients are treated by the iFR-guided percutaneous coronary intervention PCI in one stage In the control group patients are treated in accordance with the standard practice of angiography-guided staged approach

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: None